510(k) Report

510(k) · Cleared

Recalled · 2005

Coaguchek PT.S Test for Prothrombin Time Self-Testing

K030845510(k) TraditionalCleared May 22, 200366-day reviewClass II21 CFR 864.7750Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · GJS Test, Time, Prothrombin

Cleared on May 22, 2003 as substantially equivalent to K962571 (Boehringer Mannheim Corp., 1997) after a 66-day review. Its family tree reaches back 1 generation to 1997. 3 later devices descend from it. It has been recalled once.

Decided
May 22, 2003
Review
66 days
Class
Class II
Product code
GJS
Recalls
1
Predicates
1

Its longest line of descent runs back 1 generation to K962571 (1997). 3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2019: 1 descendant cleared2022: 1 descendant clearedK962571 · Coaguchek PST System · Boehringer Mannheim Corp. · 1997 · recalled1995200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant K962571 · Coaguchek PST System · Boehringer Mannheim Corp. · 1997 · recalled0
  1. Root · 1 generation backK962571 Coaguchek PST SystemBoehringer Mannheim Corp. · 1997 · Recalled
  2. This deviceK030845 Coaguchek PT.S Test for Prothrombin Time Self-TestingRoche Diagnostics Corp. · 2003
  3. Descendant · cites it directly · 2 of its ownK093243 Coagusense Self-Test Prothrombin Time/Inr Monitoring SystemCoagusense, Inc. · 2010 · Recalled
  4. Descendant · 2 generations on · 1 of its ownK183255 Coag-Sense Prothrombin Time (PT) / INR Monitoring DeviceCoagusense, Inc. · 2019 · Recalled
  5. Descendant · 3 generations on · 0 of its ownK212779 Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient…Coagusense, Inc. · 2022

Most influential descendants

Showing 3 of 3 · See all
  • K093243Coagusense Self-Test Prothrombin Time/Inr Monitoring SystemCoagusense, Inc. · 2010 · cites it directly2descendants
  • K183255Coag-Sense Prothrombin Time (PT) / INR Monitoring DeviceCoagusense, Inc. · 2019 · 2 generations on1descendant
  • K212779Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingCoagusense, Inc. · 2022 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K962571Coaguchek PST SystemBoehringer Mannheim Corp.19974
0 (this device)K030845Coaguchek PT.S Test for Prothrombin Time Self-TestingRoche Diagnostics Corp.2003—
+1K093243Coagusense Self-Test Prothrombin Time/Inr Monitoring SystemCoagusense, Inc.20101
+2K183255Coag-Sense Prothrombin Time (PT) / INR Monitoring DeviceCoagusense, Inc.20191
+3K212779Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingCoagusense, Inc.2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201910
202210
FIG. 1 — Lineage of K030845, 1997–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GJS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GJS device

  1. #1 K243543 microINR Systemscore 13.4 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K962571Coaguchek PST System
Summary page 1
…ing. Most notably, the system is substantially equivalent to the currently marketed CoaguChek System for Prothrombin Time Self-Testing (K96257 1). Continued on next page…
Boehringer Mannheim Corp.19974

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K093243Coagusense Self-Test Prothrombin Time/Inr Monitoring SystemCoagusense, Inc.20102

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 28, 2005Not classifiedZ-0098-06OtherBreaking the glass ampoule without first taking precautions may result in cuts/user injury from the glass.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K093243 (Coagusense, Inc., 2010) has gone furthest, with 2 descendants of its own.

How does its category compare?

All GJS devices

GJS Test, Time, Prothrombin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GJS

3in 2025

2007: 42008: 12010: 42012: 12013: 12014: 12016: 12017: 12018: 22019: 22020: 12022: 32023: 22024: 12025: 3
2007high 4 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GJS

60in 2025

2007: 77 days median2010: 168 days median2022: 399 days median2025: 60 days median
2007high 399 (2022) · low 60 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GJS

1in 2022

2007: 52008: 32009: 42010: 22011: 12012: 12013: 12014: 4, 3 Class I2017: 52018: 3, 2 Class I2020: 22021: 12022: 1
2007high 5 (2007) · low 0 (2015)2026

Class I (5 since 2007) Class II/III not classified

Adverse event reports per year · GJS

105in 2025

2007: 4392008: 4202009: 8762010: 2,1772011: 2,9652012: 2,1982013: 2,5842014: 2,3972015: 1,2602016: 8642017: 5322018: 1,9582019: 2,3852020: 1,3902021: 1,3592022: 1,2102023: 8092024: 1772025: 105
2007high 2,965 (2011) · low 105 (2025)2025

MAUDE reports naming product code GJS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074775439
20081—3420
20090—4876
2010416822,177
20110—12,965
20121—12,198
20131—12,584
20141—4 (3)2,397
20150—01,260
20161—0864
20171—5532
20182—3 (2)1,958
20192—02,385
20201—21,390
20210—11,359
2022339911,210
20232—0809
20241—0177
20253600105
20260—0—

What is it indicated for?

For quantitative prothrombin time testing in fresh capillary blood with the CoaguChek System by properly selected and suitably trained patients or their caregivers on the prescription or other order of the treating doctor.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K030845: Coaguchek PT.S Test for Prothrombin Time Self-Testing.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K030845

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026